Important results from the project
Intelligyn has developed an AI-driven decision support for ultrasound diagnostics of ovarian tumors. Our large validation study (nature medicine) has shown excellent results. Clinical regulatory studies are currently being conducted at Södersjukhuset, in collaboration with KI, Intelligyn and GE healthcare. The goal of the project was to write a long proposal to EIC Accelerator, as well as to perform market analyses, freedom to operate analysis and refine our business model.
Expected long term effects
We expect that the grant will lead to us being able to improve our chances of a successful EIC Accelerator-ansökan proposal, by refining our business plan and go to market strategy, based on customer feedback from ongoing clinical studies, and market analyses. The support will also help us perform a freedom to operate analysis and improve our data management plan. We were not awarded funding in May 2025 but expect to submit a new proposal in spring 2026.
Approach and implementation
We carried out, among other things:
1) Market analysis in the Nordics and selected countries in Europe
2) Refined business plan based on analysis of customer feedback
3) Coaching to write the long EIC proposal, as our short proposal was accepted
with good feedback (4/4 Go)
4) Legal ´freedom to operate analysis´
5) Coaching to improve our data management plan
The project description has been provided by the project members themselves and the text has not been looked at by our editors.
